Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic CD4 Lymphopenia”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT00001319
What this trial is testing

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

Who this might be right for
CD4 LymphocytopeniaIdiopathic CD4 Positive T Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT02113930
What this trial is testing

Idiopathic CD4 Lymphocytopenia

Who this might be right for
Idiopathic CD4 Lymphocytopenia
Assistance Publique - Hôpitaux de Paris 47
Not applicableLooking for participantsNCT00867269
What this trial is testing

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Who this might be right for
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
National Institute of Allergy and Infectious Diseases (NIAID) 950
Testing effectiveness (Phase 2)Looking for participantsNCT02015013
What this trial is testing

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Who this might be right for
Idiopathic CD4-PositiveT-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT07291986
What this trial is testing

To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.

Who this might be right for
Myopia, Moderate
Walid Osama Abdel Rahman Nour El Din 60
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT03158987
What this trial is testing

Regional Differences in Human Immunodeficiency Virus (HIV) Testing

Who this might be right for
HIV SeropositivityCD4+ T Lymphocytopenia
Jena University Hospital 999
Testing effectiveness (Phase 2)Ended earlyNCT00839436
What this trial is testing

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Who this might be right for
Idiopathic CD4+ T-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableLooking for participantsNCT07146737
What this trial is testing

Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation

Who this might be right for
ICLVaultDeep Learning+1 more
Second Affiliated Hospital of Nanchang University 818
Early research (Phase 1)Looking for participantsNCT04097561
What this trial is testing

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Looking for participantsNCT05600920
What this trial is testing

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 60